ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2026
[
Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesTo clarify whether
methodsAdult C57BL/6 mice were randomized into Sham group, unilateral ureteral obstruction (UUO) model group, and UUO with QSG treatment group (
resultsCompared with the sham-operated mice, the UUO mice showed impaired renal function, renal tubular injury, collagen deposition, upregulated expressions of IL-6 and TNF-α mRNA and α-SMA protein, and downregulated E-cad protein expression, which were significantly improved by QSG treatment. In AAV9 experiments, the UUO mice with control virus injection showed obvious renal fibrosis and increased M1 macrophages, while AAV9-shRNA(Akt3)‑GFP injection significantly alleviated renal fibrosis and inhibited M1 macrophage polarization without affecting M2 macrophages. In the co-cultured cells, treatment with QSG-medicated serum significantly reversed TGF-β1-induced reduction of HK-2 cell viability and proliferation, upregulated Akt3 and α‑SMA expressions, downregulated E-cad expression, and inhibited M0-to-M1 polarization of THP-1 cells induced by TGF‑β1-treated HK-2 cells.
conclusionsQSG alleviates renal fibrosis in UUO mice by inhibiting Akt3-mediated M1 macrophage polarization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.